Category Archives: Vioxx

Featured Stories

Actos, Avandia May Up Risk for Diabetic Macular Edema

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Google Searches Could Help FDA Identify Drug Side Effects

Google Searches Could Help FDA Identify Drug Side Effects

The Food and Drug Administration (FDA) has asked for Google’s help in identifying previously unknown side effects of medications. Last month, in a conference call, FDA officials spoke with a senior Google researcher who co-authored a 2013 paper about using search query … Continue reading

Posted in Health Concerns, Pharmaceuticals, Vioxx | Tagged , , , , |

Mis-marketing of Drugs Cost Billions, Endangers Health

Mis-marketing of Drugs Cost Billions, Endangers Health

A new report from the Center for Economic and Policy Research (CEPR) describes the high costs associated with the mis-marketing of prescription drugs, both in dollars and in health consequences. Spending on prescription drugs has consistently been the fastest growing … Continue reading

Posted in Avandia, Defective Products, Health Concerns, Pharmaceuticals, Vioxx | Tagged , , , , |

Vioxx Off-Label Marketing To Cost Merck $321 Million

Vioxx off-label marketing activities are going to cost Merck & Co. a whopping $321 million in criminal fines. The U.S. Food & Drug Administration (FDA) approved Vioxx (rofecoxib), a painkiller, for three indications in May 1999. Merck has pleaded guilty … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx | Tagged |

Vioxx Caused Complications Months After Patients Dropped It

< "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (Generic: rofecoxib), Merck’s blockbuster painkiller, might be responsible for blood clots in patients after they stopped taking it, write U.S. researchers, said Reuters. Vioxx, was approved for use in 1999, quickly becoming a bestseller for Merck, with annual … Continue reading

Posted in Pharmaceuticals, Vioxx |

Supreme Court Gives Go Ahead to Vioxx Investor Lawsuit

Yesterday, the U.S. Supreme Court gave the go-ahead for a securities fraud lawsuit against pharmaceutical giant, Merck & Co Inc., over its disclosures to investors about < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx, said Reuters. Vioxx, was approved for use in 1999, quickly becoming a … Continue reading

Posted in Class Action Lawsuits, Health Concerns, Pharmaceuticals, Vioxx, Vioxx |

Vioxx Settlement Almost Wrapped Up

Merck & Co. has made a final $4.1 billion payment to its < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx settlement fund. According to an Associated Press report, final payouts to former Vioxx users or their survivors should be made by the end of June. Vioxx … Continue reading

Posted in Pharmaceuticals, Vioxx |

Doctor Accused of Falsifying Drug Studies Pleads Guilty

Dr. Scott S. Reuben, former chief of acute pain at the Bay State Hospital in Springfield, Massachusetts, has pleaded guilty to one count of health care fraud. As we’ve reported previously, Reuben was charged in federal court last month with … Continue reading

Posted in Pharmaceuticals, Vioxx |

Vioxx Scandal Didn’t Lead To Changes At FDA

The < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx scandal, and the Food & Drug Administration’s (FDA) role in it, has not brought about much change at the agency, according to a new government report. Vioxx was approved for use in 1999, and quickly became a … Continue reading

Posted in Pharmaceuticals, Vioxx |

Vioxx Shareholder Lawsuit Before US Supreme Court

Readers of this blog are, by now, aware of the many issues surrounding Merck’s blockbuster nonsteroidal, anti-inflammatory medication < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (rofecoxib) and negative cardiac events. The cardiac problems associated with Vioxx, and its subsequent withdrawal from the market, spawned scores … Continue reading

Posted in Pharmaceuticals, Vioxx, Vioxx |

Vioxx Dangers Should Have Been Known Years Before Recall

We have long been writing about the links between Merck’s blockbuster nonsteroidal, anti-inflammatory medication < "http://www.yourlawyer.com/topics/overview/vioxx">Vioxx (rofecoxib) and negative cardiac events. Now, according to Science Daily, a study has found that evidence of cardiovascular risks linked to Vioxx might have … Continue reading

Posted in Pharmaceuticals, Vioxx |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.